SCHEMBL12601596

SCHEMBL12601596

Cc1cc(Br)ccc1NS(=O)(=O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ BRD1 O95696 1/20 0.41
▸ BRPF1 P55201 1/20 0.41
▸ BRPF3 Q9ULD4 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ MAPT P10636 4/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SLC22A12 Q96S37 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ METAP2 P50579 1/20 0.38
▸ EDNRB P24530 2/20 0.38
▸ EDNRA P25101 2/20 0.38
▸ NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1542958 0.80 ALDH1A1 (0.53) IDH1SIGMAR1MAPTKMT2AMEN1
SCHEMBL24435816 0.79 BRD4 (0.45) IDH1BRD4MAPTKMT2AMEN1
SCHEMBL15001572 0.79 SLC22A12 (0.42) CA1CA2KMT2AMEN1SLC22A12
SCHEMBL31046908 0.78 METAP2 (0.60) MAPTKMT2AMEN1ALDH1A1METAP2
SCHEMBL23141230 0.78 METAP2 (0.60) MAPTKMT2AMEN1ALDH1A1METAP2
SCHEMBL27183080 0.77 THRB (0.42) IDH1SIGMAR1MAPTKMT2AMEN1
SCHEMBL12649965 0.76 CA1 (0.43) IDH1CA1CA2SIGMAR1MAPT
SCHEMBL23141236 0.74 METAP2 (0.47) ALDH1A1METAP2
SCHEMBL12932924 0.74 ALDH1A1 (0.50) CA2ALDH1A1THRBNPC1RAB9A
SCHEMBL14864698 0.72 SIGMAR1 (0.45) SIGMAR1MAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 — — US disclosed
Send feedback